BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30558081)

  • 21. 68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancer.
    Gupta P; Murthy V; Agarwal A; Maitre M; Mhatre N; Rangarajan V
    Nucl Med Commun; 2019 Dec; 40(12):1283-1288. PubMed ID: 31688498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of CT in detecting pelvic lymph node metastases in cases of bladder and prostate carcinoma.
    Salo JO; Kivisaari L; Rannikko S; Lehtonen T
    Scand J Urol Nephrol; 1986; 20(4):261-5. PubMed ID: 3810056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
    Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
    Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
    Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
    Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes.
    Gandaglia G; Soligo M; Battaglia A; Muilwijk T; Robesti D; Mazzone E; Barletta F; Fossati N; Moschini M; Bandini M; Joniau S; Karnes RJ; Montorsi F; Briganti A
    Eur Urol; 2019 May; 75(5):817-825. PubMed ID: 30409676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using
    Nehra A; Parker WP; Haloi R; Park SS; Mynderse LA; Lowe VJ; Davis BJ; Quevedo JF; Johnson GB; Kwon ED; Karnes RJ
    J Urol; 2018 Mar; 199(3):726-733. PubMed ID: 28916273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
    Grivas N; Wit E; Pos F; de Jong J; Vegt E; Bex A; Hendricksen K; Horenblas S; KleinJan G; van Rhijn B; van der Poel H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):347-354. PubMed ID: 28068243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
    Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
    J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic implications of prostatic anterior fat pad.
    Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY
    Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.
    Li Y; Diao F; Shi S; Li K; Zhu W; Wu S; Lin T
    Chin J Cancer; 2018 Jan; 37(1):3. PubMed ID: 29370848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic nodal imaging.
    Hedgire SS; Pargaonkar VK; Elmi A; Harisinghani AM; Harisinghani MG
    Radiol Clin North Am; 2012 Nov; 50(6):1111-25. PubMed ID: 23122041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
    Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
    Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostatic cancer with cystic formation: a case report].
    Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1996 Dec; 42(12):977-80. PubMed ID: 9013236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Radiotherapy for Lesions Detected via
    Pan J; Wei Y; Zhang T; Liu C; Hu X; Zhao J; Gan H; Liu W; Zhu B; Wu J; Wang B; Song S; Ye D; Zhu Y
    Eur Urol Oncol; 2022 Aug; 5(4):420-427. PubMed ID: 35304107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
    Kava BR; Dalbagni G; Conlon KC; Russo P
    Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
    Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
    Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.